Which Tests Should Be Done Before Starting GLP-1 Treatment?

The evaluation before starting GLP-1 treatment is important to understand whether the medication is suitable for the person and to help the treatment progress more safely. This evaluation should not be made only based on weight, blood sugar or body mass index. The person’s general metabolic status, kidney and liver functions, existing diseases, medications used and side effect risk should be addressed together.

GLP-1 treatment may come up because of diabetes, obesity, insulin resistance or weight-related metabolic risks. However, physician evaluation is required before starting treatment in every case. The tests to be performed should be personalized according to the person’s diabetes status, age, weight, family history, complaints and current health risks.

Why Is Evaluation Before GLP-1 Treatment Important?

Because GLP-1 medications affect appetite, blood sugar, gastric emptying and metabolic processes, the person’s general health status should be known before treatment. This evaluation helps both understand suitability for treatment and determine the parameters to be followed during treatment.

The World Health Organization states that GLP-1 therapies in adults living with obesity should be prescribed by a physician, taking into account the person’s health history and clinical indications. This approach strengthens the importance of personal evaluation and regular medical follow-up before treatment.

Blood Sugar And Diabetes Evaluation

Before GLP-1 treatment, blood sugar status should definitely be evaluated. Because these medications play a role in blood sugar regulation, and the treatment plan may differ especially in people with type 2 diabetes, prediabetes or insulin resistance. In people diagnosed with diabetes, interaction with current treatments and the risk of hypoglycemia should also be considered.

Blood sugar evaluation helps understand with which metabolic goal the person will start treatment. Even if treatment is planned for weight management, fasting blood sugar, HbA1c and, when necessary, measurements related to insulin resistance clarify the general picture. These data allow comparison during the starting and follow-up process of treatment.

Which Tests Can Be Requested For Blood Sugar?

Blood sugar tests are one of the basic headings for evaluating diabetes or prediabetes risk. The physician may request all or some of these tests depending on the person’s condition.

• Fasting Blood Sugar: It is used in the basic evaluation of blood sugar level.
• HbA1c: It gives information about average blood sugar control over the last 2-3 months.
• Post-Meal Blood Sugar: It may help evaluate the blood sugar response after meals.
• Fasting Insulin: It may provide additional information in people with suspected insulin resistance.
• HOMA-IR: It may give an idea about insulin resistance through fasting glucose and insulin.
• Review Of Diabetes Medications: A GLP-1 plan should be made more carefully together with current medications.

Kidney Function Tests

Evaluation of kidney functions before GLP-1 treatment is important. Kidney health may affect the treatment plan especially in people with diabetes, hypertension, history of kidney disease or older age. In addition, if nausea, vomiting or fluid loss occurs during treatment, kidney functions may become more sensitive.

Kidney evaluation is necessary not only for medication safety but also to understand the person’s general metabolic risk. Since diabetes and obesity may increase risks related to kidney health, knowing baseline values makes the follow-up process easier.

Which Tests Can Be Requested For The Kidneys?

Kidney functions can be evaluated with blood and urine tests. The physician may plan a more detailed examination according to the person’s risk status.

• Creatinine: It is one of the basic blood tests used to evaluate kidney function.
• eGFR: It gives information about the kidney’s filtering capacity.
• Urea: It may provide supportive information about kidney functions and fluid balance.
• Electrolytes: Sodium, potassium and other electrolytes are important for fluid balance.
• Urinalysis: It can be evaluated for protein, glucose or infection findings.
• Microalbuminuria: It may help notice kidney involvement early in people with diabetes or hypertension risk.

Liver Functions And Metabolic Evaluation

Before starting GLP-1 treatment, liver functions and metabolic indicators should also be evaluated. Since fatty liver, insulin resistance and obesity can often be seen together, this area has an important place in the treatment plan. The baseline level of liver enzymes is useful for comparison during follow-up.

Metabolic evaluation is not limited only to liver enzymes. When cholesterol, triglycerides, blood sugar, blood pressure, waist circumference and weight status are addressed together, the person’s cardiometabolic risk is better understood. This evaluation clarifies with which goals GLP-1 treatment is planned.

Which Tests Can Be Requested For Liver And Metabolism?

These tests help understand the person’s metabolic risks and baseline status before treatment. If the physician considers it necessary, additional imaging or advanced tests may also be requested.

• ALT And AST: They may provide information about liver cell damage or liver functions.
• GGT: It is a supportive parameter in terms of liver and bile ducts.
• ALP And Bilirubin: They can be used in bile duct and liver evaluation.
• Lipid Profile: LDL, HDL, total cholesterol and triglyceride levels are important for cardiometabolic risk.
• Liver Ultrasound: Imaging may be needed if fatty liver is suspected.
• Waist Circumference And Body Mass Index: They are basic measurements in metabolic risk evaluation.

Should Thyroid Functions Be Evaluated?

Evaluation of thyroid functions before GLP-1 treatment is especially important in people with weight change, fatigue, hair loss, feeling cold, palpitations, menstrual irregularity or family history of thyroid disease. Thyroid hormones are closely related to metabolic rate, energy level and weight balance.

In addition, because some GLP-1 medications include warnings regarding certain thyroid tumor histories, personal and family history should be questioned carefully. This does not mean that the same tests will be done in everyone; however, knowing thyroid-related risks before treatment provides a safer approach.

Which Tests Can Be Requested For Thyroid?

Thyroid evaluation is planned according to the person’s symptoms and risk status. In some people, simple blood tests may be sufficient, while imaging may be needed in some situations.

• TSH: It is used in the basic evaluation of thyroid functions.
• Free T4: It provides additional information about thyroid hormone level.
• Free T3: It may be added to metabolic evaluation in some cases.
• Thyroid Antibodies: They may be requested if autoimmune thyroid disease is suspected.
• Thyroid Ultrasound: It can be evaluated if there is a nodule, enlargement or family history.
• Family History Questioning: History of thyroid cancer or endocrine tumors is important for treatment decision.

Evaluation For Pancreas And Gallbladder

Before GLP-1 treatment, pancreas and gallbladder history should be questioned carefully. History of pancreatitis, gallstones, gallbladder surgery, frequent abdominal pain or digestive complaints increasing after fatty meals may affect the treatment plan. Therefore, the person’s previous diagnoses and abdominal symptoms should definitely be evaluated.

If severe and persistent abdominal pain, pain radiating to the back, persistent vomiting, jaundice or dark urine develops during GLP-1 treatment, health support should be obtained without delay. Knowing risks before treatment helps possible side effects be noticed earlier.

Which Evaluations Can Be Done For Pancreas And Gallbladder?

Pancreatic enzymes or imaging are not needed in every person; however, if there is risk history, the physician may request a more detailed evaluation.

• History Of Pancreatitis: Whether pancreatic inflammation has been experienced before should be questioned.
• History Of Gallstones: Gallbladder stones or surgery history is important for the treatment plan.
• Amylase And Lipase: They may be evaluated if there is pancreatic complaint or risk history.
• Abdominal Ultrasound: It can be used if gallstones or fatty liver are suspected.
• History Of Abdominal Pain: Especially recurrent and severe pain should be taken into consideration.
• Digestive Complaints: Nausea, vomiting, bloating or early satiety may affect treatment tolerance.

Blood Count, Vitamin And Mineral Levels

Since GLP-1 treatment may reduce appetite and change food intake, it may be useful to evaluate the general nutritional status before treatment. Vitamin and mineral levels become important especially in people with fatigue, hair loss, weakness, dizziness or a history of irregular nutrition.

In the weight loss process, not only fat loss but also muscle mass, protein intake and micronutrient balance are important. Therefore, knowing some deficiencies before starting treatment helps plan the process more healthily. If necessary, nutrition support and dietitian follow-up can be added to the treatment plan.

Which Blood Values Can Be Evaluated?

These tests may vary according to personal complaints and health history. The aim is to see deficiencies and general health status more clearly before treatment.

• Complete Blood Count: It provides information about anemia, infection findings and general blood cells.
• Ferritin And Iron: They are important in the evaluation of iron deficiency and fatigue.
• Vitamin B12: It is necessary for the nervous system, energy and blood cell production.
• Vitamin D: It is related to bone health, immunity and general well-being.
• Folate: It is important for blood formation and cellular functions.
• Albumin And Total Protein: They may provide supportive information about nutritional status.

Should Cardiovascular Risk Be Evaluated?

Cardiovascular risk should also be considered when planning GLP-1 treatment. Obesity, type 2 diabetes, hypertension, high cholesterol and insulin resistance are closely related to cardiovascular health. Therefore, blood pressure, lipid profile, family history and existing heart diseases should be evaluated.

Some GLP-1 treatments may especially come up in people with cardiometabolic risk profiles. However, the person’s heart health, medications used and current risks should be addressed holistically by a physician. Evaluation before treatment also determines which parameters will be followed during monitoring.

What Is Considered In Cardiovascular Evaluation?

Cardiovascular risk cannot be understood with a single test only. The person’s measurements, blood values, family history and lifestyle should be evaluated together.

• Blood Pressure Measurement: The presence of hypertension may affect the treatment plan.
• Lipid Profile: Cholesterol and triglyceride levels are important in risk evaluation.
• Family History: History of early heart disease should be considered.
• ECG: It may be requested for heart rhythm and general evaluation when necessary.
• Waist Circumference: It is one of the practical indicators of cardiometabolic risk.
• Smoking: It should definitely be questioned in terms of cardiovascular risk.

Should Pregnancy And Breastfeeding Status Be Questioned?

Before starting GLP-1 treatment, pregnancy planning, current pregnancy or breastfeeding status should definitely be questioned. These medications require special evaluation during pregnancy and breastfeeding. Therefore, in women of reproductive age, the possibility of pregnancy and contraception plan should be discussed before treatment decision.

Weight management or metabolic treatment plan can be addressed differently in women planning pregnancy. Starting treatment, when to stop treatment and alternative approaches should be determined by the physician. In this process, gynecology, internal medicine or endocrinology evaluation can be planned together.

Why Should Medications Used And Health History Be Reviewed?

Before GLP-1 treatment, all medications, supplements and existing diseases used by the person should be evaluated. Diabetes medications, insulin, blood pressure medications, blood thinners, stomach medications, psychiatric medications and supplements may affect the treatment plan. Medication adjustment may be needed especially in people with a risk of low blood sugar.

Health history is as important as tests. Pancreatitis, gallbladder disease, thyroid nodule, eating disorder, serious gastrointestinal diseases, kidney or liver problems may be decisive in the treatment decision. Therefore, before starting GLP-1 treatment, not only laboratory results but the person’s entire clinical history should be evaluated.

Which Values Should Be Followed During GLP-1 Treatment?

After GLP-1 treatment starts, follow-up is necessary for the safety and effectiveness of treatment. Weight change, appetite status, side effects, blood sugar, HbA1c, kidney functions, liver enzymes and nutritional status can be monitored at certain intervals. Follow-up frequency is determined according to the person’s risks.

During treatment, dose increase, side effects, nutritional adherence and goals should be evaluated regularly. If the person experiences significant nausea, vomiting, abdominal pain, fatigue, dizziness, low blood sugar or signs of dehydration, they should consult a healthcare professional without waiting for the follow-up appointment.

Are Tests Before GLP-1 The Same For Everyone?

The tests to be done before starting GLP-1 treatment are not the same for everyone. The needs of a person with diabetes and a person evaluated only because of obesity may differ. Likewise, the evaluation scope of a young individual without chronic disease and an older individual using multiple medications may not be the same.

Therefore, standard test lists seen online should not be applied directly. The most appropriate approach is for a physician to make an individual evaluation according to the person’s complaints, goals, risks and health history. Tests are tools that support the treatment decision; they should not be seen as a reason to start treatment alone.

Happ Health Online Internal Medicine And Endocrinology Evaluation Before GLP-1

If you are considering starting GLP-1 treatment, you can access online  endocrinology evaluation through Happ Health. Blood sugar, HbA1c, kidney and liver functions, thyroid status, metabolic risks, medications used and your health history can be addressed together with specialist evaluation.

Happ Health, as a digital health platform, offers a solution that provides access to healthcare services from home or remotely. Through the online health application, you can share your current test results, learn which tests you may need and make a safer, personal and planned health evaluation before starting GLP-1 treatment.